Samuel H. Zwillich - Med Dev Grp, Pfizer Inc

基本信息

浏览量：51

职业迁徙

个人简介

暂无内容

研究兴趣

论文共 105 篇作者统计合作学者相似作者

按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选

Rates of Infections, Malignancies, Cardiovascular Outcomes, and Death in Individuals with Hospital-treated Alopecia Areata: A Registry-based Cohort Study in Denmark

Sissel Brandt Toft Sørensen, Prethibha George, Oladayo Jagun,Robert Wolk,Lynne Napatalung,Samuel H Zwillich,Lars Iversen,Vera Ehrenstein

Acta dermato-venereologica (2025): adv42646-adv42646

引用0浏览0WOS引用

Sustained Hair Regrowth with Continued Ritlecitinib Treatment Through Week 48 in Patients with Alopecia Areata with or Without Early Target Responses: Post Hoc Analysis of the ALLEGRO Phase 2b/3 Trial

Melissa Piliang,Charles Lynde,Brett King,Paradi Mirmirani,Rodney Sinclair,Maryanne Senna,Seth Forman,Lindsey Bordone,Pablo De La Cueva Dobao,Robert Wolk,Samuel H. Zwillich,Helen Tran,Dalia Wajsbrot,Haytham Mohamed Ahmed,Liza Takiya

JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGYno. 2 (2025): 276-284

引用0浏览0引用

Patterns of Clinical Response in Patients with Alopecia Areata Treated with Ritlecitinib in the ALLEGRO Clinical Development Programme

B King,P Mirmirani,K Lo Sicco,Y Ramot,R Sinclair,L Asfour,K Ezzedine,C Paul,M Ohyama,R A Edwards, G Bonfanti,U Kerkmann,D Wajsbrot, R Ishowo-Adejumo,S H Zwillich,A Lejeune

Journal of the European Academy of Dermatology and Venereology JEADVno. 6 (2025): 1163-1173

引用0浏览0WOS引用

Using Patient Preference to Inform Ritlecitinib Dose Selection for Alopecia Areata Treatment

Brett Hauber,Chiara Whichello,Jonathan Mauer,Ernest Law,Myrto Trapali,Edward Whalen,Dalia Wajsbrot,Nicolas Krucien,Tommi Tervonen,Samuel H. Zwillich,Robert Wolk

JOURNAL OF DERMATOLOGY (2025)

引用0浏览0WOS引用

Relationship Between Lymphocyte Count and Risk of Infection in Japanese Rheumatoid Arthritis Patients Treated with Tofacitinib

Yoshiya Tanaka,Tsutomu Takeuchi,Hernan Valdez,Mark Collinge,Samuel H. Zwillich,Shigeyuki Toyoizumi,Kenneth Kwok,Tomohiro Hirose

Modern Rheumatology (2024)

引用0浏览0WOS引用

Integrated Safety Analysis of Ritlecitinib, an Oral JAK3/TEC Family Kinase Inhibitor, for the Treatment of Alopecia Areata from the ALLEGRO Clinical Trial Program

Brett King,Jennifer Soung,Christos Tziotzios,Lidia Rudnicka,Pascal Joly,Melinda Gooderham,Rodney Sinclair,Natasha A. Mesinkovska,Carle Paul, Yankun Gong,Susan D. Anway,Helen Tran,Robert Wolk,Samuel H. Zwillich,Alexandre Lejeune

American Journal of Clinical Dermatology（2024）

引用7浏览0WOS引用

The Epidemiology of Hospital-Treated Alopecia Areata in Denmark, 1995–2016

Sissel Brandt Toft Sørensen,Prethibha George,Oladayo Jagun,Robert Wolk,Lynne Napatalung,Samuel H. Zwillich,Lars Iversen,Vera Ehrenstein

DERMATOLOGY AND THERAPY（2024）

引用0浏览0WOS引用

Patient-Reported Satisfaction with Hair Regrowth in a Study of Ritlecitinib in Alopecia Areata: Results from ALLEGRO-2b/3

Rodney Sinclair,Ernest H. Law,Xingqi Zhang,Fan Zhang,Lynne Napatalung,Samuel H. Zwillich,Brett King,Natasha Mesinkovska

DERMATOLOGYno. 5-6 (2024): 767-777

引用0浏览0WOS引用

Target Occupancy and Functional Inhibition of JAK3 and TEC Family Kinases by Ritlecitinib in Healthy Adults: an Open‐Label, Phase 1 Study

David A. Martin,Jean-Baptiste Telliez,Susan Pleasic-Williams,Ying Zhang,Brendan Tierney,Matthew Blatnik,Jeremy D. Gale,Chris Banfield, Yifan Zhou,Alexandre Lejeune,Samuel H. Zwillich,Erin Stevens, Neeraj Tiwari,Elizabeth Kieras, Ashwin Karanam

JOURNAL OF CLINICAL PHARMACOLOGYno. 1 (2024): 67-79

引用1浏览0WOS引用

A Phase 2a Study Investigating the Effects of Ritlecitinib on Brainstem Auditory Evoked Potentials and Intraepidermal Nerve Fiber Histology in Adults with Alopecia Areata

Samira Anderson,Guido Cavaletti,Linda J. Hood,Michael Polydefkis,David N. Herrmann,Gary Rance,Brett King,Amy J. McMichael,Maryanne M. Senna,Brian S. Kim,Lynne Napatalung,Robert Wolk,Samuel H. Zwillich,Gregor Schaefer, Yankun Gong,Melanie Sisson,Holly B. Posner

PHARMACOLOGY RESEARCH & PERSPECTIVESno. 4 (2024)

引用0浏览0WOS引用

加载更多

作者统计

合作学者

合作机构

D-Core

合作者
学生
导师

暂无相似学者，你可以通过学者研究领域进行搜索筛选

数据免责声明

页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果，我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问，可以通过电子邮件方式联系我们：report@aminer.cn